📉 Se me han bajado los niveles de dopamina, y la única cura es: vacaciones.😎 La ciencia puede seguir sin mí… al menos unos días (o eso quiero creer). 😂😂 👋 Nos vemos cuando recupere mi homeostasis.

Paper accepted! We’re thrilled and ready to celebrate a job well done. More details coming soon… but today, we raise a glass. 🥂 Stay tuned! #Science #Research

Salir a correr en Córdoba después de las 9:00 a.m. no es deporte, es una prueba de supervivencia. Se llama: 100 metros deshidratado estilo lagarto en asfalto. 🦎🔥💀🏃🏻🏃🏻‍♂️

Excited to share that I’m now part of the Editorial Board of Oncogene. I’ve long been a fan of the journal and look forward to contributing to its continued excellence #Oncogene #NaturePublishingGroup www.nature.com/onc/

Springer-Nature launched a series of "Discover" journals that closely mimic MDPI titles -- sharing *identical* journal names, and likely similar business model. What is going on, and why researcher will - as always - fall for it? A 🧵 the-strain-on-scientific-publishing.github.io/website/post...

To accelerate #mRNA vaccine and therapy research, we're excited to share our end-to-end protocol for mRNA design, synthesis and encapsulation in @natprot.nature.com. Protocol development led by @laura-leighton.bsky.social, Natasha Chaudhary and Tim [email protected] rdcu.be/eqiF1

Off goes the revised manuscript, fatter and wiser after surviving another round of experiments. May the reviewers be kind, merciful… and slightly distracted. 🤞📤 #Resubmitted #ReviewerBeNice

Amazing discovery 🙀 www.nature.com/articles/s41...

Researchers in Science have developed a tool to silence specific mitochondria-encoded mRNAs in living cells, which could help scientists understand the origins of certain mitochondria-related diseases. scim.ag/3F6Wm5d

The papers all follow a similar template and make misleading claims https://go.nature.com/4kucwEH

Proteasome: An antibiotic arsenal in anti-bacterial innate immunity

Researchers report that their new #AI has, in a matter of months, conjured up dozens of GPCR-targeting antibody candidates, which promise to work as well as drugs that have spent years in the traditional pipeline. scim.ag/3S4gjwb

A new #ScienceAdvances study identifies a neuroimmune pathway for treating sepsis, finding that dopamine inhibits expression of a critical regulator of immunometabolism. This suggests that pramipexole, a dopamine agonist, could effectively treat lethal infections. scim.ag/4kfAfrZ

Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial

The @ukdri.ac.uk is recruiting a Research Associate to investigate how E3 ubiquitin ligases drive degradation of protein aggregates in neurodegenerative disease. Closing date: 25th May www.dementiaresearcher.nihr.ac.uk/job/research...

Targeting an overlooked protein complex could offer a fresh avenue to cancer therapy https://go.nature.com/3Z8R7IJ

Nature research paper: Cell cycle duration determines oncogenic transformation capacity. https://go.nature.com/3GBSklB

Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels. Full ALPACA trial results and Research Summary: nej.md/4kWjJyn #MedSky #CardioSky

Nos conocimos hace 16 años como Ramón y Cajal y hemos compartido mucho desde entonces. Hoy, Catedráticos de Química Analítica, Ing. Hidráulica e Inmunología. Excelentes profesionales y mejores personas. La #uco tiene suerte de tenerlos a ambos como Profesores e Investigadores.

Article submitted!

Why don’t you wear a suit? 🤮😔

Hoy, #DíaMundialContraElCáncer, recordamos que la investigación es clave. Hemos avanzado mucho en terapias dirigidas e inmunoterapia, pero aún queda mucho por hacer. Seguimos trabajando para entender mejor el cáncer y desarrollar mejores tratamientos. @univcordoba.bsky.social @imibic.bsky.social

Today, we had the privilege of having @prieto-garcia.bsky.social at @IMIBIC talking about splicing, USP38, and proteostasis. A magnificent talk and excellent work! 🧬🧪🧫

It was great to share Science with people at the IMIBIC! Great place 🙂. Really thanks to Manuel D. Gahete for the invitation and thanks to @marcoacalzado.bsky.social , Raul , @betsaidaop.bsky.social and others for nice time and plenty Scientific discussions.

1, 2, 3….. probando. Early adopter